Henry Schein, Inc. HSIC SPX
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -9.6% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HSIC Henry Schein, Inc. SPX | 76.58 | 23.14 | $8.72B | - | 8.55% | 8.76% | 1.40% | -9.56% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Apr 2017 | Jul 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Apr 2023 | Jul 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 2.27B | 2.32B | 2.36B | 2.47B | 2.36B | 2.45B | 9.99B | 2.67B | 2.43B | 1.68B | 2.84B | 3.17B | 2.92B | 2.97B | 3.18B | 3.18B | 3.03B | 3.07B | 3.06B | 3.10B | 3.16B | 3.17B | 3.14B | 3.17B | - | 3.17B | 3.24B | 3.34B | 3.44B | 3.37B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.17B | 2.22B | 2.31B | 2.37B | 2.30B |
| Gross Profit | 748.91M | 799.28M | 777.84M | 801.47M | 787.67M | 859.49M | 822.92M | 839.17M | 836.05M | 900.96M | 719.13M | 718.33M | 722.36M | 750.93M | 751.69M | 767.43M | 761.17M | 810.60M | 746.01M | 454.27M | 754.27M | 859.71M | 891.00M | 891.00M | 912.00M | 973.00M | 945.00M | 914.00M | 966.00M | 975.00M | 995.00M | 1.01B | 1.02B | 993.00M | - | 1.00B | 1.02B | 1.03B | 1.06B | 1.07B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 800.00M | 842.00M | 828.00M | 877.00M | 876.00M |
| Operating Income | 188.88M | 200.69M | 176.19M | 180.68M | 200.72M | 213.98M | 193.97M | 210.66M | 213.55M | 241.19M | 162.24M | 157.11M | 123.27M | 158.00M | 172.44M | 162.29M | 187.20M | 196.33M | 173.87M | -7.43M | 187.67M | 181.20M | 230.00M | 210.00M | 211.00M | 244.00M | 220.00M | 211.00M | 175.00M | 201.00M | 200.00M | 150.00M | 159.00M | 157.00M | - | 200.00M | 174.00M | 198.00M | 186.00M | 194.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 253.00M | 235.00M | 252.00M | 241.00M | 270.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.00M | 38.00M | 38.00M | 39.00M | 39.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 145.00M | 121.00M | 134.00M | 133.00M | 150.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.00M | 31.00M | 28.00M | 32.00M | 38.00M |
| Net Income | 127.73M | 129.95M | 113.75M | 120.10M | 133.71M | 139.22M | 140.75M | 136.06M | 138.03M | -8.54M | 111.53M | 110.64M | 90.77M | 117.78M | 109.78M | 114.53M | 140.56M | 330.61M | 130.26M | -10.80M | 141.70M | - | 166.00M | 156.00M | 162.00M | 181.00M | 160.00M | 150.00M | 121.00M | 140.00M | 137.00M | 93.00M | 104.00M | 99.00M | - | 110.00M | 86.00M | 101.00M | 101.00M | 107.00M |
| Diluted EPS | 1.52 | 1.56 | 0.69 | 0.73 | 0.82 | 0.86 | 0.88 | 0.86 | 0.87 | -0.06 | 0.72 | 0.72 | 0.59 | 0.77 | 0.78 | 0.78 | 0.91 | 2.25 | 0.91 | -0.08 | 0.99 | 0.99 | 1.16 | 1.10 | 1.15 | 1.30 | 1.16 | 1.09 | 0.91 | 1.06 | 1.05 | 0.72 | 0.80 | 0.78 | - | 0.88 | 0.70 | 0.84 | 0.85 | 0.92 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 8.88B | 9.42B | 9.99B | 10.12B | - | 12.65B | 12.34B | 12.67B | 13.18B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.82B | 8.48B | 8.66B | 9.08B |
| Gross Profit | 1.87B | 1.92B | 2.17B | 2.42B | 2.51B | 2.66B | 2.91B | 3.01B | 3.23B | 2.75B | 2.91B | 3.09B | 2.82B | - | 3.83B | 3.86B | 4.02B | 4.11B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.95B | 3.17B | 3.29B | 3.35B |
| Operating Income | 419.29M | 464.08M | 521.13M | 582.15M | 618.96M | 677.05M | 715.14M | 733.97M | 771.57M | 669.76M | 600.62M | 718.26M | 535.00M | - | 878.00M | 695.00M | 731.00M | 758.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 950.00M | 851.00M | 912.00M | 964.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.00M | 87.00M | 131.00M | 150.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 721.00M | 542.00M | 513.00M | 533.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 170.00M | 120.00M | 128.00M | 126.00M |
| Net Income | 239.46M | 311.15M | 325.79M | 367.66M | 388.08M | 431.55M | 466.08M | 479.06M | 506.78M | 406.30M | 535.88M | 694.73M | 404.00M | - | 538.00M | 416.00M | 390.00M | 398.00M |
| Diluted EPS | 2.63 | 3.44 | 3.49 | 3.97 | 4.32 | 4.93 | 5.44 | 2.85 | 3.10 | 2.57 | 3.49 | 4.65 | 2.82 | - | 3.91 | 3.16 | 3.05 | 3.27 |
Compounded Sales Growth
| 5 Years: | 1.40% |
| 1 Year: | 6.30% |
Compounded Profit Growth
| 5 Years: | -9.56% |
| 1 Year: | 4.50% |
Stock Price Performance
| 1 Year: | +9.42% |
| 6 Months: | +1.43% |
| 3 Months: | -7.05% |
| 1 Month: | +3.77% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 3.60B | 3.84B | 4.55B | 4.74B | 5.33B | 5.62B | 6.14B | 6.53B | 6.81B | 7.86B | 8.50B | 7.15B | 7.77B | - | 8.61B | 10.57B | 10.22B | 11.21B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.99B | 4.49B | 3.98B | 4.46B |
| Cash & Equivalents | 247.59M | 369.57M | 471.15M | 150.35M | 147.28M | 122.08M | 188.62M | 89.47M | 72.09M | 62.38M | 174.66M | 80.21M | - | - | - | 117.00M | 171.00M | 122.00M | 156.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.96B | 1.81B | 1.81B | 2.00B |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.44B | 1.86B | 1.48B | 1.65B |
| Total Liabilities | - | - | 1.50B | 1.83B | 1.90B | 2.28B | 2.34B | 2.76B | 3.08B | 3.35B | 4.21B | 4.65B | 3.23B | 3.46B | - | 3.94B | 5.42B | 5.38B | 6.42B |
| Current Liabilities | - | - | 1.08B | 1.17B | 1.27B | 1.47B | 1.55B | 1.78B | 2.15B | 2.32B | 2.83B | 3.22B | 2.04B | 2.28B | - | 2.22B | 2.68B | 2.80B | 3.23B |
| Long Term Debt | - | - | 243.37M | 395.31M | 363.52M | - | - | - | - | - | - | - | - | - | - | 1.04B | 1.94B | 1.83B | 2.31B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.50B | 2.74B | 2.87B | 3.44B |
| Total Equity | - | - | 2.16B | 2.41B | 2.43B | 2.61B | 2.79B | 2.81B | 2.88B | 2.79B | 2.81B | 2.96B | 3.00B | 3.35B | - | 3.45B | 3.65B | 3.39B | 3.25B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 131.79M | 129.25M | 124.16M | 115.77M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 384.78M | 398.03M | 395.48M | 554.62M | 408.10M | - | - | 615.50M | 642.58M | 545.51M | 684.71M | 654.09M | 599.00M | - | 602.00M | 500.00M | 848.00M | 712.00M |
| Investing Cash Flow | -168.01M | -98.59M | -387.62M | -193.22M | -269.60M | - | - | -260.03M | -316.42M | -342.28M | -192.95M | -424.37M | -115.00M | - | -276.00M | -1.14B | -430.00M | -400.00M |
| Financing Cash Flow | -87.97M | -197.68M | -330.64M | -357.21M | -170.60M | - | - | -348.03M | -327.34M | -112.55M | -603.78M | -215.98M | -187.00M | - | -315.00M | 701.00M | -510.00M | -188.00M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -128.00M | -187.00M | -187.00M | -191.00M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 474.00M | 313.00M | 661.00M | 521.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.00M | 66.00M | -92.00M | 124.00M |
| Share Buybacks | 82.79M | 0 | 57.73M | 200.00M | 299.88M | 300.25M | 299.99M | 299.85M | 550.02M | 450.00M | 200.00M | 525.00M | 74.00M | 401.00M | 485.00M | 250.00M | 385.00M | 850.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | 30.9% | 30.9% | 31.0% | 27.8% | - | 30.3% | 31.3% | 31.7% | 31.1% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | 7.5% | 6.4% | 7.2% | 5.3% | - | 6.9% | 5.6% | 5.8% | 5.7% |
| Net Margin % | - | - | - | - | - | - | - | - | - | 4.6% | 5.7% | 7.0% | 4.0% | - | 4.3% | 3.4% | 3.1% | 3.0% |
| ROE % | - | 14.4% | 13.5% | 15.1% | 14.8% | 15.5% | 16.6% | 16.6% | 18.1% | 14.5% | 18.1% | 23.2% | 12.1% | - | 15.6% | 11.4% | 11.5% | 12.3% |
| ROCE % | - | 16.8% | 15.4% | 16.8% | 16.0% | 16.6% | 16.4% | 16.7% | 17.2% | 13.3% | 11.4% | 14.0% | 9.7% | - | 13.8% | 8.8% | 9.9% | 9.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Kohlberg Kravis Roberts & Co. L.P. | 13.74% | 15.65M | $1.20B |
| 2 | Blackrock Inc. | 6.17% | 7.02M | $537.82M |
| 3 | Artisan Partners Limited Partnership | 5.77% | 6.57M | $503.36M |
| 4 | Vanguard Capital Management LLC | 5.64% | 6.42M | $491.89M |
| 5 | FMR, LLC | 5.02% | 5.72M | $438.20M |
| 6 | Invesco Ltd. | 4.29% | 4.89M | $374.21M |
| 7 | JPMORGAN CHASE & CO | 4.01% | 4.56M | $349.40M |
| 8 | State Street Corporation | 3.84% | 4.38M | $335.34M |
| 9 | Vanguard Portfolio Management LLC | 3.68% | 4.19M | $321.25M |
| 10 | American Century Companies Inc | 3.16% | 3.59M | $275.26M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HSIC